Innovation Unleashed: REPROCELL's Q1 Recap and Insights
13 July 2023
REPROCELL had a productive first quarter of 2023-24, launching new services, winning grants, and publishing research. Find out more in our news release.
End of Q4 update from REPROCELL (2022-23)
04 May 2023
Did you know that REPROCELL is celebrating its 20th anniversary this year? If you missed the commemorative letter from our CEO you can find out more here.
Celebrating the 20th Anniversary of REPROCELL: A letter from our CEO Chikafumi Yokoyama
28 February 2023
On February 26 2023 REPROCELL celebrated its 20th anniversary. In this letter, the company CEO reflects on the history of REPROCELL to the present day.
End of Q3 update from REPROCELL (2022-23)
12 December 2022
The final months of 2022 have brought new collaborations, partnerships, and successes to enrich your stem cell and drug discovery research.
End of Q2 update from REPROCELL (2022-23)
03 October 2022
Read the end of Q2 update from REPROCELL for the financial year 2022-23. Discover the latest website updates, blog, and news updates.
REPROCELL will participate at the Biotechgate Digital Partnering Event.
21 April 2021
This is announcement REPROCELL USA and REPROCELL Europe will be attending Biotechgate Digital Partnering 2021.
REPROCELL Becomes VIP Supplier on Scientist.com Biotech Marketplace
10 December 2020
Find out about how REPROCELL, an industry leader in the use of human biospecimens for medical research has achieved VIP supplier status on scientist.com
Appointment of New Distributor in Thailand
04 November 2019
Read about the REPROCELL groups distributorship agreement with A.N.H. Scientific Marketing Co. Ltd. to distribute REPROCELL’s products and services in Thailand
PRESS RELEASE: Axion BioSystems make REPROCELL a product distributor
28 August 2019
Axion BioSystems has announced REPROCELL as the new distributor of its Maestro products in Japan. Read the official Press Release at reprocell.com
Appointment of New Distributor in China
01 February 2019
The REPROCELL group has signed non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s group products in China.
REPROCELL’s footprint extends to serve life sciences in India
13 June 2018
Learn more about REPROCELL India's expansion into the life sciences industry through the integration of Oligonucleotide Services and Next Generation Sequencing
Derek Mackay, SNP Cabinet Secretary for Finance and the Constitution, visits REPROCELL Europe, Glasgow
06 April 2018
Read about REPROCELL's visit from Derek Mackay, the Scottish National Party’s Cabinet Secretary for Finance and the Constitution, on 05 April 2017
REPROCELL’s David Bunton addresses the Scottish Parliament
21 March 2018
Discussing how sectors, such as life science, are affected by Scotland’s economic performance and what actions are required to make the economy more inclusive, innovative and international. Topics include key factors in company success, SME’s and government partnership.
REPROCELL Launches New Global Website
15 January 2018
Today, REPROCELL rolled out its new comprehensive global website demonstrating the synergies and power of the full portfolio of products and services.
Nicola Sturgeon: interview at the official opening of REPROCELL’s Centre for Predictive Drug Discovery (YouTube video)
10 August 2017
Video: First Minister Nicola Sturgeon officially opened the new European headquarters of a life sciences company which is set to generate 15 new jobs and safeguard a further three following new investment.
Press Release: Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow
10 August 2017
REPROCELL Europe Ltd (REPROCELL), a leading provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture and a member of the REPROCELL Group, has opened its European headquarters in Glasgow, UK.
REPROCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan
14 February 2017
Read about the REPROCELL CEO's meeting with Fiona Hyslop, Cabinet Secretary for Culture, Tourism and External Affairs for the Scottish Government
Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination
07 February 2017
Read about REPROCELL CEO Dr David Bunton's nomination for the Scottish Enterprise Association Life Science Business Leadership Award
REPROCELL acquires Biopta to expand its drug discovery services
25 November 2015
The Japanese regenerative medicine company REPROCELL Inc. has announced the acquisition of the Scottish life sciences company, Biopta.
REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)
09 September 2014
REPROCELL announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. allowing REPROCELL to expand the product lineup of its iPSC Business